Eric Legras … THEDOCTORFACTORY … Health & Wellness Strategic Marketing


Biograph mCT: from vision to reality by Aléxia Herms

Siemens.com

Just coming online in hospitals around the world, the new Biograph® mCT represents the first true integration of modalities, says Paul Shreve, MD, Medical Director of PET/CT (positron emission therapy/computed tomography) at the Lemmen-Holton Cancer Pavilion at Spectrum Health’s Grand Rapids campus in Michigan, USA. “It’s just one, on-the-fly, integrated process,” Shreve says. “It’s an improvement over anything available right now.”

Faster, clearer images

Siemens’ Biograph mCT sets technological standards for both CT and PET modalities. Its unmatched CT isotropic resolution combined with one of the industry’s best rotation times, offers crisp anatomical details in every scan – both routine and advanced – while limiting motion artifacts. Its powerful ultraHD•PET technology delivers highly detailed images with up to four times as much contrast as earlier hybrids, providing uniform resolution throughout field of view. Scan time is greatly reduced – as little as five minutes are needed for a whole-body scan, resulting in greater throughput and less patient discomfort.

 Seeing the future in every image

The Biograph mCT’s unique short tunnel and 78-centimeter bore is capable of scanning patients as large as 500 pounds (227 kilograms), while also potentially alleviating stress in patients. Greater detail with lower radiation is a benefit to patients, while providing doctors with less degradation of image, even in large patients. Greater integration of modalities, on-the-fly parameter adjustments, and more detailed images mean an advancement in the diagnosis and treatment of cancer. Additional tumors may be able to be spotted, and effectiveness of chemotherapy will be determined more quickly. “We’re able to get a simultaneous view of whether the agent is acting metabolically and anatomically,” says Fadlo Khuri, MD, Professor and Chair of the Department of Hematology and Medical Oncology at Emory University in Atlanta, Georgia. “I think that the future of drug development and response assessment in oncology is tied to the development of these modalities.”

 Key Benefits

  • Faster scan times mean greater throughput and less patient discomfort
  • Greater resolution of CT and PET images, with four times as much contrast and tumors as small as two-mm visible
  • Potential for quicker determination of the effectiveness of chemotherapy
  • Capable of handling patient weights up to 500 lb (227 kg)

  


Dejar un comentario so far
Deja un comentario



Responder

Introduce tus datos o haz clic en un icono para iniciar sesión:

Logo de WordPress.com

Estás comentando usando tu cuenta de WordPress.com. Cerrar sesión / Cambiar )

Imagen de Twitter

Estás comentando usando tu cuenta de Twitter. Cerrar sesión / Cambiar )

Foto de Facebook

Estás comentando usando tu cuenta de Facebook. Cerrar sesión / Cambiar )

Google+ photo

Estás comentando usando tu cuenta de Google+. Cerrar sesión / Cambiar )

Conectando a %s



A %d blogueros les gusta esto: